Effects of berberine on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and a rat model of Parkinson's disease

Neuroscience Letters

Volumn 486, Issue 1, 2010, Pages 29-33

  Kwon, Ik Hyun ^a   Choi, Hyun Sook ^a   Shin, Kun Seong ^a   Lee, Byung Koo ^b   Lee, Chong Kil ^a   Hwang, Bang Yeon ^a   Lim, Sung Cil ^a   Lee, Myung Koo ^a  

^a Chungbuk National University   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

6 Hydroxydopamine induced cytotoxicity; 6 Hydroxydopamine lesioned rats; Berberine; Dopaminergic neuronal cells; PC12 cells

Indexed keywords

BERBERINE; DOPAMINE; LEVODOPA; NORADRENALIN; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN; CELL VIABILITY; CORPUS STRIATUM; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; FLOW CYTOMETRY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; BERBERINE; CELL DEATH; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; NEUROTOXICITY SYNDROMES; NOREPINEPHRINE; OXIDOPAMINE; PARKINSONIAN DISORDERS; PC12 CELLS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 77957892635     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.09.038     Document Type: Article

References (30)

1. Basma A.N., Morris E.J., Nicklas W.J., Geller H.M. l-DOPA cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 1995, 64:825-832.
2. Blum D., Torch S., Lambeng N., Nissou M., Benabid A.L., Sadoul R., Verna J.M. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 2001, 65:135-172.
3. Cheng N., Maeda T., Kume T., Kaneko S., Kochiyama H., Akaike A., Goshima Y., Misu Differential neurotoxicity induced by l-DOPA and dopamine in cultured striatal neurons. Brain Res. 1996, 743:278-283.
4. Deumens R., Blokland A., Prickaerts J. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp. Neurol. 2002, 175:303-317.
5. Fearnley M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991, 114:2283-2301.
6. Jahnke G.D., Price C.J., Marr M.C., Myers C.B., George J.D. Developmental toxicity evaluation of berberine in rats and mice. Birth Defects Res. B: Dev. Reprod. Toxicol. 2006, 77:195-206.
7. Kim S.H., Shin J.S., Lee J.J., Yin S.Y., Kai M., Lee M.K. Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 2001, 67:609-613.
8. Kim Y.M., Kim M.N., Lee J.J., Lee M.K. Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett. 2005, 386:1-4.
9. Kumar R., Agarwal A.K., Seth P.K. Free radical-generated neurotoxicity of 6-hydroxydopamine. J. Neurochem. 1995, 64:1703-1707.
10. Lee M.K., Zhang Y.H. Inhibition of tyrosine hydroxylase by berberine. Med. Sci. Res. 1996, 24:561-564.
11. Maharaj H., Sukhdev Maharaj D., Scheepers M., Mokokong R., Daya S. l-DOPA administration enhances 6-hydroxydopamine generation. Brain Res. 2005, 1063:180-186.
12. Makino Y., Ohta S., Tachikawa O., Hirobe M. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compounds related to Parkinson's disease. Life Sci. 1988, 43:373-378.
13. Mitsui A., Nohta H., Ohkura Y. High-performance liquid chromatography of plasma catecholamines using 1,2-diphenylethylenediamine as precolumn fluorescence derivatization reagent. J. Chromatogr. 1985, 344:61-70.
14. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Met. 1983, 65:55-63.
15. Neil A., David B. Parkinson's disease. Medicine 2008, 12:630-635.
16. Paxions G., Watson C. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Australia.
17. Peng W.H., Lo K.L., Lee Y.H., Hung T.H., Lin Y.C. Berberine produces antidepressant-like effects in the forced swim test and in the tail suspension test in mice. Life Sci. 2007, 81:933-938.
18. Peng W.H., Wu C.R., Chen C.S., Chen C.F., Leu Z.C., Hsieh M.T. Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors. Life Sci. 2004, 75:2451-2462.
19. Przedborski S., Levivier M., Jiang H., Ferreira M., Jackson-Lewis V., Donaldson D., Togasaki D.M. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience 1995, 67:631-647.
20. Ren T., Sagar S.M. Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine. Brain Res. Bull. 1992, 29:589-597.
21. Sauer H., Oertel W.H. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 1994, 59:401-415.
22. Shin J.S., Kim E.I., Kai M., Lee M.K. Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 2000, 25:363-368.
23. Shin J.S., Yun-Choi H.S., Kim E.I., Lee M.K. Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 1999, 65:452-455.
24. Tischler A.S., Perlman P.L., Morse G.M., Sheard B.E. Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures. J. Neurochem. 1983, 40:364-370.
25. Toshiharu N. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 1997, 29:99-111.
26. Walkinshaw G., Waters C.M. Induction of apoptosis in catecholaminergic PC12 cells by l-DOPA. Implications for the treatment of Parkinson's disease. J. Clin. Invest. 1995, 95:2458-2464.
27. Wu J.F., Liu T.P., Wang J.X., Yang S.J. Effect of berberine on intracellular free Ca2+ concentration in cultured brain cells. Yao Xue Xue Bao 1997, 32:15-18.
28. Yin S.Y., Kim Y.M., Lee J.J., Jin C.M., Yang Y.J., Ma J.J., Kang M.H., Kai M., Lee M.K. Enantio-selective inhibition of (1R,9S)- and (1S,9R)-β-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacology 2004, 47:1045-1052.
29. Zhang Y.H., Shin J.S., Lee S.S., Kim S.H., Lee M.K. Inhibition of tyrosine hydroxylase by bulbocapnine. Planta Med. 1997, 63:362-363.
30. Zhu F., Qian C. Berberine chloride can ameliorate the spatial memory impairment and increase the expression of interleukin-1 beta and inducible nitric oxide synthase in the rat model of Alzheimer's disease. BMC Neurosci. 2006, 7:78-87.